BRCA2 and breast cancer: Within the group of 46 women diagnosed with TNBC between 45 and 60 years of age but without a significant family history of breast cancer, three (6.5%) harbored mutations in ATM (n = 1), BAP1 (n = 1), or BRCA2 (n = 1).